Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda (1993)
Chapter: B7. Comments on Session II
Unfortunately, this book can't be printed from the OpenBook.
If you need to print pages from this book, we recommend
downloading it as a PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter:
B6. Uses of Antiprogestins After 63 Days of Amenorrhea
Next Chapter: B8. Use of Antiprogestins in the Management of Endometriosis and Leiomyoma
Suggested Citation:
"B7. Comments on Session II." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B7. Comments on Session II." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B7. Comments on Session II." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B7. Comments on Session II." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B7. Comments on Session II." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B7. Comments on Session II." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.